Phosphatidylserine UFLPA Compliance: A Review for U.S. Importers

Navigating phosphatidylserine UFLPA compliance requires a rigorous, evidence-based approach to supply chain traceability and vendor management. For U.S. importers of record, the Uyghur Forced Labor Prevention Act (UFLPA) establishes a strict statutory presumption that impacts all bulk ingredient shipments originating from or processed in China. Although phosphatidylserine and lecithin-based raw materials are not currently listed on the U.S. Customs and Border Protection (CBP) high-priority sector appendix, the UFLPA’s core presumption is entirely product-agnostic. This means any commercial importation of bulk nutritional ingredients can be subject to CBP detention and review if supply chain due diligence is incomplete.

Establishing compliance means recognizing that the importer of record bears the ultimate legal responsibility for proving the origin of their goods. A supplier cannot be "UFLPA certified," and a non-XUAR production address does not automatically clear a shipment. Instead, compliance requires assembling clear, convincing, and highly organized documentary evidence that traces the ingredient from the agricultural raw material stage through extraction, processing, and final packaging. This resource outlines how CBP’s June 2026 importer guidance frames forced-labor diligence, what specific documentation is required to support an applicability or exception review, and how procurement teams can align with their manufacturing partners to build robust entry files. *Note: This guide provides operational procurement guidance, not legal certainty. Importers must confirm all shipment-specific compliance decisions and entry strategies with a licensed U.S. customs broker or trade attorney.*

UFLPA Compliance Quick Reference Checklist

When preparing to import bulk phosphatidylserine from China, procurement and quality teams must expand their standard vendor qualification process to include UFLPA-specific verification. The table below outlines the difference between standard quality documentation and the specific evidence required for forced-labor due diligence.

Understanding the UFLPA Statutory Presumption

The Uyghur Forced Labor Prevention Act (Public Law 117-78) was signed into law on December 23, 2021. Its most critical enforcement mechanism—the rebuttable presumption—took effect shortly thereafter on June 21, 2022. Understanding the statutory mechanics of this law is the foundational step for any U.S. buyer sourcing soy phosphatidylserine or sunflower phosphatidylserine from international supply chains.

Under Section 3 of the Act, CBP applies a statutory presumption that any goods mined, produced, or manufactured wholly or in part in the Xinjiang Uyghur Autonomous Region (XUAR) of China, or produced by an entity actively listed on the UFLPA Entity List, are inherently prohibited from importation into the United States. This prohibition is enforced under Section 307 of the Tariff Act of 1930 (19 U.S.C. 1307), which prohibits the entry of goods produced, wholly or in part, with forced labor. When the presumption is triggered, the goods are not entitled to entry and will be detained at the U.S. port of arrival.

The Rebuttal Standard

The UFLPA presumption is not an absolute ban on all Chinese goods, but overcoming it requires meeting a high evidentiary bar. The presumption is rebutted only when the importer of record has fully complied with all statutory guidance, completely and substantively responded to all CBP inquiries, and demonstrated by clear and convincing evidence that the goods were not produced wholly or in part by forced labor.

The "clear and convincing" standard is significantly higher than a standard commercial preponderance of evidence. It requires an unbroken, fully documented chain of custody from the farm level to the final export container. If there is a single gap in the documentation—such as missing payment records for a raw soybean or sunflower seed supplier—CBP may determine that the presumption has not been rebutted.

The UFLPA Entity List

Procurement teams must regularly monitor the UFLPA Entity List as part of their phosphatidylserine supplier onboarding process. This consolidated register is maintained by the Forced Labor Enforcement Task Force (FLETF) and published by the Department of Homeland Security (DHS), with regular updates posted in the Federal Register. If a manufacturer, agricultural cooperative, or logistics provider appears on this list, any goods they touch are subject to the presumption. Importers must screen not only their direct tier-one supplier but also tier-two and tier-three raw material processors.

CBP’s June 2026 Operational Guidance: The New Standard

In June 2026, U.S. Customs and Border Protection published the *Forced Labor Enforcement Operational Guidance for Importers* (CBP Publication No. 5560-0526). This critical update superseded the original June 2022 UFLPA Operational Guidance, creating a unified framework for importers. The June 2026 guidance is highly significant because it consolidates enforcement protocols across 19 U.S.C. 1307 (Withhold Release Orders and Findings), the UFLPA, and the Countering America’s Adversaries Through Sanctions Act (CAATSA).

Reasonable Care Duty

The most crucial shift in the June 2026 guidance is how it frames forced-labor due diligence as an inseparable component of the importer's "reasonable care" duty under 19 U.S.C. 1484. Prior to this, some importers treated forced-labor checks as an isolated compliance task. Now, CBP explicitly expects that verifying supplier practices, conducting rigorous supply-chain audits, and maintaining traceability to the raw-material stage are standard requirements for entering goods into the U.S. commerce stream.

Failing to conduct this diligence before filing entry—such as failing to complete your phosphatidylserine ISF filing checklist with accurate manufacturer data—can leave cargo detained while the documentation package is assembled and can put the importer's reasonable-care record under scrutiny under 19 U.S.C. 1484.

High-Priority Sectors vs. Product-Agnostic Enforcement

The June 2026 guidance includes a high-priority sector appendix that identifies industries at severe risk for forced labor. This appendix covers aluminum, apparel, caustic soda, copper, cotton and cotton products, lithium, PVC, red dates (jujubes), seafood, silica-based products (including polysilicon), steel, and tomatoes and downstream products.

Notably, phosphatidylserine, soluble soybean polysaccharide, and other lecithin-based nutritional ingredients are *not* listed on this high-priority sector appendix. However, buyers must not misinterpret this omission as a safe harbor. The statutory presumption of the UFLPA is entirely product-agnostic. CBP possesses the authority to detain any shipment of any commodity if risk algorithms or intelligence suggest a nexus to the XUAR or an entity list party.

Active Enforcement Tools and the Threat Landscape

CBP utilizes three primary enforcement tools to restrict goods made with forced labor: detentions, exclusions, and seizures. When a bulk ingredient shipment arrives at a U.S. port, CBP may issue a detention notice if they suspect UFLPA applicability. Following a detention, the importer may request an applicability review (arguing the UFLPA does not apply because the supply chain has no nexus to XUAR/Entity List) or an exception review (arguing that while there is a nexus, clear and convincing evidence proves no forced labor was used).

To understand the enforcement landscape, procurement teams should utilize the CBP UFLPA enforcement dashboard and the Withhold Release Orders (WRO) and Findings dashboard. As of mid-2026, CBP reported 58 active WROs and 9 active Findings across all commodities globally. While no current public WRO targets lecithin or phospholipid ingredients, the enforcement dashboard's overall shipment counts underline why proactive phosphatidylserine lot traceability matters before a shipment moves.

Official Resources for Importers

CBP’s guidance lists several practical due-diligence resources that procurement teams should integrate into their daily compliance workflows. These include:

• The UFLPA Entity List
• The WRO and Findings Dashboard
• The comprehensive UFLPA Strategy document
• The U.S. Department of Labor List of Goods Produced by Child Labor or Forced Labor
• The Xinjiang Supply Chain Business Advisory

Relying exclusively on standard commercial documents like a basic phosphatidylserine certificate of origin is no longer sufficient; buyers must cross-reference their supplier network against these federal databases.

If you are unsure how these requirements impact your upcoming bulk orders, the Nutranexa sales and technical teams can provide current ingredient specifications and document files for your broker's review. Contact us to discuss your documentation needs.

Documentary Evidence for Applicability and Exception Reviews

If a shipment of phosphatidylserine is detained, the importer must submit a highly organized, comprehensive data package to CBP. The June 2026 guidance describes exactly what types of evidence are expected for applicability and exception reviews. Gathering this data requires a transparent, cooperative relationship with your manufacturer.

1. Supply Chain Tracing and Entity Roles

Importers must provide a complete supply-chain description. This is not simply naming the final factory; it requires mapping every entity involved from the agricultural harvest of soybeans or sunflowers through to the final extraction and packaging of the phosphatidylserine. Buyers must maintain detailed supplier lists with verified physical addresses and direct contact information for all tier-one, tier-two, and tier-three facilities.

2. Transactional and Transportation Documents

To prove the unbroken chain of custody, the documentation must financially and logistically link every step of the process. CBP expects to see a matched set of transactional documents that correspond exactly to the detained shipment. This includes:

• Purchase orders and commercial invoices
• Packing lists and detailed bills of materials (BOM)
• Certificates of origin covering both the raw material and the finished good
• Payment records (e.g., wire transfer confirmations showing the manufacturer paid the raw material processor)
• Inventory records showing how the specific lot of raw material was drawn down to produce the specific lot of finished PS
• Shipping records and bills of lading

For example, when conducting a phosphatidylserine COA and specification review, the lot number on the COA must be traceable backward through the factory's inventory logs directly to the incoming shipment of raw lecithin.

3. Corporate Social Responsibility and Audits

For exception reviews, importers must provide evidence regarding the supplier's internal labor controls. This includes a written supplier code of conduct, evidence of regular employee training, continuous monitoring, and remediation protocols. Furthermore, independent verification of these systems is heavily scrutinized.

Crucially, CBP guidance is clear regarding the nature of audits: audits must specifically examine the International Labour Organization (ILO) indicators of forced labor. Financial audits, standard GMP quality audits, or environmental audits alone are not sufficient to rebut the presumption. Importers must gather specific worker information, including evidence of consistent wage payments, production output metrics matching workforce size, and controls demonstrating that all recruitment and work is strictly voluntary.

4. Submission Best Practices

How the evidence is presented to CBP is almost as important as the evidence itself. A disorganized data dump will likely result in an unfavorable determination. The June 2026 guidance emphasizes strict submission best practices. All submitted files must be clearly labeled and accompanied by a numbered exhibit list that cross-references the documents to the importer's narrative argument. Documents must be submitted as OCR-searchable PDFs to allow CBP personnel to search for specific entities or lot numbers. Finally, original documents must be provided alongside complete and accurate English translations.

Evaluating Supplier Documentation: The Nutranexa Approach

Because the importer of record owns the UFLPA response file, selecting a manufacturer capable of supplying granular, batch-specific evidence is critical. Nutranexa operates through its primary manufacturing entity, Shandong Baianrui Biopharmaceutical Co., Ltd., which was founded in 2013. The company operates a 110,000+ m2 production campus in Shandong Province, with a primary export focus in Europe and North America.

Facility Location and UFLPA

Nutranexa’s manufacturing facility is located in Shandong Province, which is geographically distant and completely separate from the Xinjiang Uyghur Autonomous Region (XUAR). However, importers must remember a critical UFLPA compliance fact: a production address outside the XUAR does not by itself rebut the UFLPA presumption.

CBP is well aware of transshipment risks and the movement of raw materials across provincial lines. Therefore, even when buying from a Shandong-based facility, buyers must still verify raw-material origin, map all subcontractors, perform regular entity-list screening, and maintain perfect shipment records.

Documentation Support for Importers

Nutranexa is a functional food ingredient manufacturer focused on phosphatidylserine, soy PS, sunflower PS, and soluble soybean polysaccharide. To support U.S. importers in meeting their reasonable care obligations and adhering to FDA food facility registration guidelines, Nutranexa provides current PS specifications, COA evidence, and shipment-support documentation for buyer review.

For standard bulk orders (which feature a 25 kg Minimum Order Quantity packaged at 25 kg net per drum), Nutranexa supplies detailed PS Certificates of Analysis (COA) and specification evidence. Beyond standard quality documents, our quality and R&D teams can provide factory floor, raw material packaging, and dispatch imagery that visually corroborates the documentary trail.

Furthermore, Nutranexa provides verified business-license and production-license documentation for the Shandong Baianrui Biopharmaceutical Co., Ltd. facility. Crucially for UFLPA tracing, the sales team can match current documents directly to the quoted product, the specific logistical route, and the exact production batch, ensuring that your customs broker has a cohesive, translated document packet to present upon entry. R&D cooperation information is also available for buyer review.

To ensure physical labeling aligns with documentary evidence, buyers should also review our guide on phosphatidylserine country of origin marking before finalizing their packaging specifications.

Perguntas frequentes

Does a non-XUAR production address exempt our PS shipment from UFLPA review?

No. While Nutranexa’s production facility is located in Shandong Province, a production address outside the XUAR does not by itself rebut the UFLPA presumption. CBP requires importers to prove the origin of the raw materials (the soybeans or sunflower seeds) and verify that no subcontractors involved in the extraction or refining process are located in the XUAR or listed on the UFLPA Entity List. The importer of record owns the UFLPA response file and must present this complete supply chain map if detained.

Are phosphatidylserine or lecithin ingredients on the UFLPA high-priority list?

As of the June 2026 CBP Operational Guidance appendix, phosphatidylserine, lecithin, and soluble soybean polysaccharides are not listed as high-priority sectors (which currently target goods like cotton, polysilicon, and tomatoes). However, the UFLPA statutory presumption is product-agnostic. CBP can and will detain any product from China if they suspect a supply chain nexus to forced labor.

What happens if our shipment is detained for a UFLPA review?

If your shipment is detained, CBP will issue a detention notice. You will then have an opportunity to submit documentation for an "applicability review" (proving the UFLPA doesn't apply because there is no connection to XUAR or the Entity List) or an "exception review" (proving via clear and convincing evidence that no forced labor was used despite a geographic nexus). You must respond completely to CBP inquiries with properly translated, OCR-searchable PDFs and numbered exhibit lists.

Do financial or environmental audits satisfy CBP's forced labor due diligence?

No. According to the June 2026 guidance, financial audits, environmental impact audits, or basic GMP quality audits are not sufficient to support an exception review. Any audit submitted as evidence must specifically examine the International Labour Organization (ILO) indicators of forced labor, reviewing worker information such as wage payments, voluntary recruitment controls, and matching production output to the active workforce.

How should we format our documentation for a CBP submission?

CBP expects high levels of organization. Submission best practices dictate that all files must be clearly labeled, accompanied by a numbered exhibit list outlining the argument, formatted as OCR-searchable PDFs (to allow keyword searching), and include the original foreign-language documents alongside complete, certified English translations. Disorganized submissions are routinely rejected.

Conclusion

Securing U.S. supply chains against the risks of forced labor is a complex but necessary reality for ingredient procurement. Under the UFLPA and CBP's June 2026 guidance, the burden of proof rests entirely on the U.S. importer of record. Successful importation of bulk phosphatidylserine requires moving beyond standard commercial invoices and establishing a rigorous, traceable documentary trail that spans from the agricultural source to the final packaging drum. By partnering with transparent, well-documented manufacturers like Nutranexa—who provide batch-specific licensing, traceability data, and dispatch imagery—importers can effectively manage their reasonable care duties, avoid costly port detentions, and ensure a reliable supply of critical nutritional ingredients.

Fontes

• congress.gov PL 117-78 PDF
• govinfo 19 U.S.C. 1307
• cbp.gov/trade/forced-labor/enforcement
• cbp.gov/trade/forced-labor/UFLPA
• cbp.gov document "Forced Labor Enforcement Operational Guidance for Importers"
• cbp.gov WRO and Findings dashboard
• dhs.gov/uflpa
• dhs.gov/uflpa-entity-list

Próximas etapas recomendadas

• Revise o Phosphatidylserine página do produto.
• Comparar Soy PS e Sunflower PS.
• Verifique prova de fabricação e Qualidade e P&D.